• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非传染性疾病(NCDs)及其风险因素的一级预防策略:肠道微生物群的作用

Primary Prevention Strategy for Non-Communicable Diseases (NCDs) and Their Risk Factors: The Role of Intestinal Microbiota.

作者信息

López-Tenorio Itzel Ivonn, Aguilar-Villegas Óscar Rodrigo, Espinoza-Palacios Yoshua, Segura-Real Lorena, Peña-Aparicio Berenice, Amedei Amedeo, Aguirre-García María Magdalena

机构信息

Unidad de Investigación UNAM-INC, División de Investigación, Facultad de Medicina UNAM, Instituto Nacional de Cardiología Ignacio Cháve, Mexico City 14080, Mexico.

Consulta Externa Endocrinología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.

出版信息

Biomedicines. 2024 Nov 5;12(11):2529. doi: 10.3390/biomedicines12112529.

DOI:10.3390/biomedicines12112529
PMID:39595097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11591598/
Abstract

Non-communicable diseases (NCDs) are the leading cause of morbidity and mortality worldwide. These conditions have numerous health consequences and significantly impact patients' lifestyles. Effective long-term treatment is essential since NCDs are irreversible. Therefore, primary healthcare must be both exclusive and of the highest quality, ensuring comprehensive care. The primary goal should be to improve quality of life with a focus on patients, families, and communities, as most of these diseases can be prevented and controlled, although not cured. Several factors have been linked to individual health, including social, cultural, and economic aspects, lifestyle, and certain environmental factors, including work, that can have positive or negative effects. More of these variables may contribute to the onset of NCDs, which are defined by their chronic nature, propensity for prolongation, and generally slow rate of progression. Examples of NCDs include hypertension, type 2 diabetes (T2D), dyslipidemia, and fatty liver disease linked to metabolic dysfunction. The onset of these diseases has been associated with an imbalance in certain microbial niches, such as the gut, which hosts billions of microorganisms performing multiple metabolic functions, such as the production of metabolites like bile acids (BAs), short-chain fatty acids (SCFAs), and trimethylamine N-oxide (TMAO). Therefore, lifestyle changes and personal habits can significantly impact the gut microbiota (GM), potentially preventing chronic diseases associated with metabolism. NCDs are highly prevalent worldwide, prompting increased attention to strategies for modifying the intestinal microbiota (IM). Approaches such as probiotics, prebiotics, synbiotics, and fecal transplantation (FMT) have demonstrated improvements in the quality of life for individuals with these conditions. Additionally, lifestyle changes and the adoption of healthy habits can significantly impact IM and may help prevent chronic diseases related to metabolism. Therefore, the main aim of this review is to analyze and understand the importance of microbiota intervention in the prevention of non-communicable diseases. R3:A1.

摘要

非传染性疾病(NCDs)是全球发病和死亡的主要原因。这些疾病会引发众多健康问题,并对患者的生活方式产生重大影响。由于非传染性疾病是不可逆的,有效的长期治疗至关重要。因此,初级医疗保健必须既全面又高质量,确保提供综合护理。主要目标应该是提高生活质量,重点关注患者、家庭和社区,因为这些疾病大多可以预防和控制,尽管无法治愈。有几个因素与个人健康相关,包括社会、文化和经济方面、生活方式以及某些环境因素,包括工作,这些因素可能产生正面或负面影响。更多这些变量可能导致非传染性疾病的发生,非传染性疾病的特点是具有慢性性质、易于迁延以及通常进展缓慢。非传染性疾病的例子包括高血压、2型糖尿病(T2D)、血脂异常以及与代谢功能障碍相关的脂肪肝疾病。这些疾病的发生与某些微生物生态位的失衡有关,比如肠道,肠道中存在数十亿执行多种代谢功能的微生物,例如产生胆汁酸(BAs)、短链脂肪酸(SCFAs)和氧化三甲胺(TMAO)等代谢物。因此,生活方式的改变和个人习惯会对肠道微生物群(GM)产生重大影响,有可能预防与代谢相关的慢性病。非传染性疾病在全球高度流行,这促使人们更加关注改变肠道微生物群(IM)的策略。益生菌、益生元、合生元和粪便移植(FMT)等方法已证明可改善患有这些疾病个体的生活质量。此外,生活方式的改变和养成健康习惯会对肠道微生物群产生重大影响,并可能有助于预防与代谢相关的慢性病。因此,本综述的主要目的是分析和理解微生物群干预在预防非传染性疾病中的重要性。R3:A1。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182e/11591598/d4b072260bae/biomedicines-12-02529-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182e/11591598/d4b072260bae/biomedicines-12-02529-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/182e/11591598/d4b072260bae/biomedicines-12-02529-g001.jpg

相似文献

1
Primary Prevention Strategy for Non-Communicable Diseases (NCDs) and Their Risk Factors: The Role of Intestinal Microbiota.非传染性疾病(NCDs)及其风险因素的一级预防策略:肠道微生物群的作用
Biomedicines. 2024 Nov 5;12(11):2529. doi: 10.3390/biomedicines12112529.
2
The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.肠道细菌代谢物在非传染性疾病的人类免疫信号通路中的作用。
Gut Microbes. 2021 Jan-Dec;13(1):1-22. doi: 10.1080/19490976.2021.1882927.
3
The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis.目前关于肠-肝轴以及与肠道微生物群失调相关的非酒精性脂肪性肝病/非酒精性脂肪性肝炎分子基础的研究结果。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 9. doi: 10.1007/s00210-025-04069-z.
4
Exploring the Gut Microbiota and Cardiovascular Disease.探索肠道微生物群与心血管疾病
Metabolites. 2021 Jul 29;11(8):493. doi: 10.3390/metabo11080493.
5
Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.调节肠道菌群作为 2 型糖尿病的治疗干预手段。
Front Endocrinol (Lausanne). 2021 Apr 7;12:632335. doi: 10.3389/fendo.2021.632335. eCollection 2021.
6
Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.肠道微生物组及其在心血管疾病中的治疗干预作用。
Front Immunol. 2024 Jan 26;15:1321395. doi: 10.3389/fimmu.2024.1321395. eCollection 2024.
7
Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases.肠道微生物组成对慢性非传染性疾病的发生和发展的影响。
Nutrients. 2019 May 14;11(5):1073. doi: 10.3390/nu11051073.
8
Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization.揭示和利用人类肠道微生物组在城市化进程中非传染性疾病负担不断增加的过程中的作用。
Gut Microbes. 2023 Jan-Dec;15(1):2237645. doi: 10.1080/19490976.2023.2237645.
9
Gut-targeted therapies for type 2 diabetes mellitus: A review.2型糖尿病的肠道靶向治疗:综述
World J Clin Cases. 2024 Jan 6;12(1):1-8. doi: 10.12998/wjcc.v12.i1.1.
10
The Effect of Dietary Types on Gut Microbiota Composition and Development of Non-Communicable Diseases: A Narrative Review.膳食类型对肠道微生物组成和非传染性疾病发展的影响:叙述性综述。
Nutrients. 2024 Sep 17;16(18):3134. doi: 10.3390/nu16183134.

引用本文的文献

1
Dietary and Nutritional Strategies to Prevent Uremic Toxin Formation and Slow the Progression of Diabetic Kidney Disease.预防尿毒症毒素形成及延缓糖尿病肾病进展的饮食和营养策略。
J Clin Med. 2025 Jul 3;14(13):4701. doi: 10.3390/jcm14134701.
2
A Comprehensive Perspective on the Biological Effects of Intermittent Fasting and Periodic Short-Term Fasting: A Promising Strategy for Optimizing Metabolic Health.间歇性禁食和周期性短期禁食的生物学效应综合视角:优化代谢健康的一项前景策略。
Nutrients. 2025 Jun 20;17(13):2061. doi: 10.3390/nu17132061.